Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Information Technology
March 18, 2017 01:00 AM

Missouri opioid Rx-monitoring fight ignites debate over national program

Steven Ross Johnson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    For years, there's been debate over balancing the need to track potentially addicted patients by providing their clinicians with a vast amount of data on their prescription drug habits and maintaining the privacy of those patients' records.

    The number of overdoses caused by opioids makes the case for maintaining robust drug-monitoring databases, some experts say.

    Now the ongoing fight to track opioid prescriptions in the holdout state of Missouri has once again raised discussion on whether the country would be best served by a national monitoring system—or whether it's too late to implement that idea because the drugs causing overdoses are bought on the street.

    Missouri is the only state in the nation without a prescription-drug-monitoring program, which collects information to warn physicians that they may overprescribe opioids and prevent a patient from seeking prescriptions from multiple physicians.

    Republican Missouri state Sen. Rob Schaaf, a family physician and a longtime opponent of drug-monitoring programs, recently introduced a bill that would allow a physician to view a patient's medical data only when the state's Department of Health and Senior Services identified cases of doctor-shopping. Critics say a monitoring program just gives physicians more work, while others say it will just track the wrong addictions since drug use has shifted.

    Supporters contend a national program expands and streamlines the information available.

    “I think that there wouldn't be anyone who would disagree with the idea that it would be better to have a single national system rather than all of these different state systems,” said Dr. Andrew Kolodny, co-director of opioid policy research at Brandeis University.

    MH TAKEAWAY

    The debate over a national prescription-drug-monitoring database has gone on so long that the concept may no longer be viable.

    Kolodny said a uniform national system would solve the problem of states being unable to track interstate drug trafficking.

    State prescription drug-monitoring programs, or PDMPs, often differ in the technology they use, as well as the rules and regulations by which they operate. Also, state PDMPs differ on the frequency in which data is collected.

    But the move toward establishing a national monitoring program has never taken off because critics feel states may lose the flexibility they need to address their specific drug problems.

    “Each of these programs, in doing something different, they also do a lot of innovative things,” said Peter Kreiner, a senior scientist at the Schneider Institute for Health Policy at Brandeis University. “If you had a national program you could imagine the kind of bureaucracy that would be associated with that, and it's unlikely it would be able to innovate in nearly the way state programs can.”

    But according to Tom Bizzaro, vice president of health policy and industry relations for health data firm First Databank and a longtime supporter of a national drug-monitoring network, states would be able to keep their individual regulations and rules under a national network by applying standards that are already used by pharmacies for claims reimbursement and electronic prescribing.

    “The infrastructure is there,” Bizzaro said. “So we're not talking about having to create a pipeline for that information; that already exists.” Using that infrastructure allows for states to determine who has access to their PDMP, the kind of information that is shared, and what types of drugs would be included.

    A total of 41 states engage in some form of interstate data-sharing. But most sharing is still done on a regional basis. A physician in California may be able to easily find that a patient was prescribed opioids in Oregon, but they would not have a clue as to whether the same patient recently received a prescription for pain relievers in New York or Illinois.

    Supporters of a national PDMP network believe it would make interstate data-sharing easier. But it could also attract hackers.

    “The bigger a database gets the more practical concerns there can be about data security and the ramifications of hacking,” said Nathan Freed Wessler, a staff attorney with the American Civil Liberties Union's Speech, Privacy and Technology Project. “There may well be benefits in terms of efficiency, but in this area, I don't think the efficiency is the most important value.”

    Still others feel the whole premise of a national PDMP may be outdated considering current trends in drug use. The rate of overdose deaths by prescription pain relievers has been leveling off over the past few years, while deaths from heroin have skyrocketed from 8% of all drug overdose deaths in 2010 to 25% by 2015, according to the Centers for Disease Control and Prevention.

    “The drug problem keeps changing, keeps morphing, and keeps staying ahead of the efforts to address it,” Kreiner said. “Having a slow-moving entity that's trying to help address it is probably not a great idea.”

    Increasing scrutiny of opioid prescribing practices in the past few years has helped to reduce prescriptions. That may have led addicts to switch to heroin as prescription medications become sparser.

    “It seems like the ship may have already sailed on that,” said Bryce Pardo, a drug policy analyst with research and consulting public policy firm BOTEC Analysis Corp., referring to the database helping curb the overdose epidemic. “It seems like the market is shifting toward heroin, so it seems like we're entering the second stage of this epidemic.”

    But Kolodny said the CDC figures do not provide an accurate portrait of what is truly happening in terms of the epidemic. He said the switch from pain relievers to heroin occurred early in the drug epidemic, predominantly among younger adults, but prescription opioids remain a large concern among older Americans.

    Bizzaro believes there will someday be a national drug-monitoring program and he's gauging the Trump administration's interest in developing one.

    “I think it just makes too much sense to have a national program,” Bizzaro said. “I see it now as more of a political issue than a technical one.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    technology
    Task force to review standards for ONC-certified tech
    2015_01_29_EHR_stock_getty_doctor hands touching tablet_i.jpg
    Navigating data guidelines and regulations
    Sponsored Content
    Health IT Strategist (HITS) Newsletter: Sign up for the latest IT and medical technology news delivered 3 days a week (M, W, F).
     
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing